Literature DB >> 3942651

Hypertrophic cardiomyopathy in three generations of a large Norwegian family. A clinical, echocardiographic, and genetic study.

H Haugland, O J Ohm, H Boman, E Thorsby.   

Abstract

Hypertrophic cardiomyopathy is a heart muscle disease with an obscure aetiology. Data from four generations of a large family (71 members) are presented. The occurrence of hypertrophic cardiomyopathy among members of the two oldest generations was compatible with a pattern of autosomal dominant inheritance. Seven out of 14 siblings in the second generation had definite signs of or were clinically suspected of having hypertrophic cardiomyopathy. The severity and distribution of left ventricular hypertrophy varied, but three (21%) brothers in generation II showed the classic picture of left ventricular outflow obstruction. Four siblings (29%) died suddenly aged 11, 22, 38, and 40 years. A high incidence of the disease would have been expected in the two younger generations (41 members, aged 1-31 years), but only two, a 16 year old boy and a 17 year old girl had signs of asymmetric septal hypertrophy. Current diagnostic procedures, including M mode and cross sectional echocardiography, are not sufficiently sensitive to identify young family members who may have preclinical hypertrophic cardiomyopathy. No evidence for close genetic linkage between a postulated locus for hypertrophic cardiomyopathy and the major histocompatibility complex (antigens HLA-A, HLA-B, and HLA-DR) was found.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942651      PMCID: PMC1232113          DOI: 10.1136/hrt.55.2.168

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Dominant and recessive modes of inheritance in idiopathic cardiomyopathy.

Authors:  R Emanuel; R Withers; K O'Brien
Journal:  Lancet       Date:  1971-11-13       Impact factor: 79.321

2.  Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis.

Authors:  C E Clark; W L Henry; S E Epstein
Journal:  N Engl J Med       Date:  1973-10-04       Impact factor: 91.245

3.  Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history.

Authors:  S Frank; E Braunwald
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

4.  Subcellular fractionation studies of human rectal mucosa: localization of the mucosal peptide hormones.

Authors:  J Dawson; M G Bryant; S R Bloom; T J Peters
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

5.  Asymmetric septal hypertrophy and hypertrophic cardiomyopathy.

Authors:  R Emanuel; J Marcomichelakis; R Withers; K O'Brien
Journal:  Br Heart J       Date:  1983-04

6.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

7.  Echocardiographic measurements in normal subjects from infancy to old age.

Authors:  W L Henry; J M Gardin; J H Ware
Journal:  Circulation       Date:  1980-11       Impact factor: 29.690

8.  Familial prevalence of asymmetric septal hypertrophy.

Authors:  W G van Dorp; F J ten Cate; W B Vletter; H Dohmen; J Roelandt
Journal:  Eur J Cardiol       Date:  1976-09

9.  HLA linkage vs association in hypertrophic cardiomyopathy. Evidence for the absence of an association in a heterogeneous Caucasian population.

Authors:  J M Gardin; J S Gottdiener; R Radvany; B J Maron; M Lesch
Journal:  Chest       Date:  1982-04       Impact factor: 9.410

10.  HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.

Authors:  A Matsumori; C Kawai; A Wakabayashi; P I Terasaki; M S Park; T Sakurami; Y Ueno
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

View more
  2 in total

1.  Hypertrophic cardiomyopathy in identical twins.

Authors:  J M Reid; A B Houston; E Lundmark
Journal:  Br Heart J       Date:  1989-11

2.  Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations.

Authors:  H Watkins; L Thierfelder; D S Hwang; W McKenna; J G Seidman; C E Seidman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.